MoneyWorks4Me

Sandu Pharmaceuticals informs about quarterly statement of investor complaints

12 Apr 2016 Evaluate

Sandu Pharmaceuticals has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1724.70
Dr. Reddys Labs. 1220.95
Cipla 1299.20
Lupin 1904.00
Zydus Lifesciences 1105.20
View more..